What is Peptide Therapy? A Complete Map
Peptide therapy refers to a set of protocols that use exogenous peptides for targeted physiological regulation, covering target selection, quality control, administration routes, and cycle assessment. It is neither a single drug nor a common supplement; this page maps the five major directions, how a protocol runs, and the safety and regulatory boundaries.
What It Is (and What It Is Not)
Section titled “What It Is (and What It Is Not)”| Category | Nature | Related Pages |
|---|---|---|
| Peptide therapy (research/protocol-oriented) | Exogenous peptide regulation, mechanism- and practice-focused | This page and the whole site |
| Drugs (e.g. GLP-1 receptor agonists) | Prescription drugs, regulatory approval paths | GLP-1 head-to-head review |
| Nutritional peptides (collagen peptides, whey peptides) | Food grade, nutritional support | Oral nutraceutical peptides |
| Cosmetic peptides (topical) | Skincare ingredients, local action | Cosmeceutical peptides |
All four share the word “peptide”, but their evidence standards, regulatory paths, and risk structures are completely different. For the conceptual base, see Peptide Basics.
The Full Map: Five Directions
Section titled “The Full Map: Five Directions”| Direction | Typical Agents | Discussion Context | Deep-Dive Pages |
|---|---|---|---|
| Repair and regeneration | BPC-157, TB-500 | Tendons, ligaments, scars, nerves | BPC-157, TB-500 |
| Metabolism and weight | GLP-1 class, Tesamorelin | Weight-loss plateaus, visceral fat, muscle preservation | GLP-1 head-to-head review, weight-loss peptides |
| Cognition and mood | Semax, Selank | Brain fog, anxiety, focus | Semax & Selank, nootropic peptides |
| Skincare and hair | GHK-Cu, signal peptides | Post-procedure repair, collagen, barrier | copper peptides, cosmeceutical peptides |
| Longevity and mitochondria | Epithalon, MOTS-c, SS-31 | Cellular senescence, mitochondria | longevity trio |
Each direction has matching symptom-scenario pages on the site (sports recovery, metabolism, cognition and sleep, skin) — enter by problem, search by agent.
How a Protocol Runs
Section titled “How a Protocol Runs”- Pick the target: symptom/goal → choose the agent from the ingredient encyclopedia; only when the mechanism matches do you move on.
- Control quality: COA / HPLC / MS — batch number, purity, salt form, and content are the baseline; defusing fake reports is routine work.
- Reconstitute: for lyophilized powder, BAC water, concentration conversions, and IU markings.
- Choose the route: SubQ, nasal, oral, and transdermal — the same peptide behaves differently by route, with different bioavailability.
- Manage the cycle: storage and cold chain, onset evaluation, review and adjust.
Safety and Regulatory Boundaries
Section titled “Safety and Regulatory Boundaries”- Regulations differ widely: the same agent may be a prescription drug, a research reagent, or a gray area depending on the country/region — check local rules before you start.
- Evidence is uneven: from in vitro and animal work to small human samples and formulation observations, the chain length varies; “there is research” is not “there is a conclusion”.
- Quality risk: agents without a batch number or test reports are at your own risk; quality-control steps are covered in the practical guide.
How to Read the Evidence
Section titled “How to Read the Evidence”| Evidence Tier | What It Means | How to Use It |
|---|---|---|
| In vitro / mechanism | Cellular and pathway level | Explains “how it might work”, does not predict human effects |
| Animal studies | Effective in a model | Directional reference; doses need conversion, extrapolate cautiously |
| Small human samples | Preliminary signals | Watch endpoint measures and control design |
| Formulation / protocol observations | Real-use records | Many variables, easily confounded by vehicle and combinations |
The “Key References” and “Evidence Notes” sections across the site are written to this standard; anything uncertain is flagged directly.